jRCT1050260052招募中不适用
Pancreatic Cancer Screening Using Single-Molecule Enzyme Activity-Based Liquid Biopsy, Enzeavour: A Single-Arm Interventional Feasibility Study Protocol in Japan (ENZEAVOUR Feasibility Study)
未提供0 个研究点目标入组 10,000 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
入排标准
- 年龄范围
- No limit 至 No limit（—）
- 性别
- All
入选标准
- •Asymptomatic adults attending participating facilities for routine health checkups, organized cancer screening, or both
- •Able to understand the study procedures and provide written informed consent before enrollment
排除标准
- •Documented clinical history of pancreatic cancer
- •Considered unable or unwilling to undergo any required diagnostic imaging modality (MRCP, EUS, or contrast-enhanced CT) after a positive index test result
- •Any medical, psychological, or social condition that, in the opinion of the principal investigator at each participating site, makes participation inappropriate or compromises study integrity
研究者
相似试验
招募中
3 期
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerPancreatic CancerNCT07409272Astellas Pharma Global Development, Inc.614
尚未招募
不适用
Early Cancer Detection ConsortiumCTRI/2024/03/064152Arbor research collaborative for Health8,000
尚未招募
3 期
A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic CancerPancreatic CancerNCT07383922FutureGen Biopharmaceutical (Beijing) Co., Ltd524
尚未招募
不适用
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic CancerPancreatic Cancer, Advanced or MetastaticNCT07528430University of Maryland, Baltimore450
招募中
不适用
Biomarker discovery in pancreatobiliary cancer, solid pseudopapillary neoplasm and neuroendocrine tumor, and clinical validation of the candidate biomarkersDiseases of the digestive systemKCT0000436Yonsei University Health System, Severance Hospital40